Related Experiment Video
Updated: Dec 23, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
p53 and FBXW7: Sometimes Two Guardians Are Worse than One
María Galindo-Moreno1, Servando Giráldez1, M Cristina Limón-Mortés1
1Departamento de Microbiología, Facultad de Biología, Universidad de Sevilla, E-41012 Sevilla, Spain.
Abstract:
Too much of a good thing can become a bad thing. An example is FBXW7, a well-known tumor suppressor that may also contribute to tumorigenesis. Here, we reflect on the results of three laboratories describing the role of FBXW7 in the degradation of p53 and the possible implications of this finding in tumor cell development. We also speculate about the function of FBXW7 as a key player in the cell fate after DNA damage and how this could be exploited in the treatment of cancer disease.
Insights
The tumor suppressor FBXW7 can paradoxically promote cancer by degrading p53. Understanding this dual role is key for developing new cancer therapies targeting cell fate after DNA damage.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- FBXW7 is a known tumor suppressor.
- FBXW7's role in cancer is complex and can be context-dependent.
- The degradation of p53 by FBXW7 is a critical pathway in cell regulation.
Purpose of the Study:
- To review and synthesize findings on FBXW7's role in p53 degradation.
- To explore the implications of FBXW7-mediated p53 degradation in tumor development.
- To speculate on FBXW7's function in cell fate determination after DNA damage and its therapeutic potential.
Main Methods:
- Literature review and synthesis of existing research.
- Analysis of data from three independent laboratories.
- Speculative analysis of molecular mechanisms and therapeutic strategies.
Main Results:
- FBXW7 facilitates the degradation of the tumor suppressor p53.
- This degradation can contribute to tumorigenesis, highlighting a paradoxical role for FBXW7.
- FBXW7 influences cell fate decisions following DNA damage.
Conclusions:
- FBXW7's dual role as a tumor suppressor and promoter necessitates careful consideration in cancer research.
- Targeting the FBXW7-p53 pathway may offer novel therapeutic avenues for cancer treatment.
- Further investigation into FBXW7's function in DNA damage response is warranted for clinical applications.
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....

